Firefly Neuroscience, Inc.
AIFF
$3.20
-$0.01-0.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.75% | -239.32% | -12.66% | -4.18% | -65.69% |
| Total Depreciation and Amortization | 0.00% | 0.00% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.42% | 4,253.45% | -1.69% | -13.24% | -13.92% |
| Change in Net Operating Assets | 278.79% | -836.89% | 140.23% | -151.30% | 421.94% |
| Cash from Operations | 51.65% | -129.21% | 16.68% | -158.63% | 29.75% |
| Capital Expenditure | -1,900.00% | 93.75% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 104.71% | 27.35% | 10.69% | 66.06% | -- |
| Cash from Investing | 14.61% | 50.83% | -38.17% | 66.06% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -75.17% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -46.15% | -- | -100.00% | -55.96% | 68.71% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.49% | 168.13% | -153.47% | -140.40% | 128.94% |